JHS Svendgaard Laboratories7.90
+0.04 (+0.51%)

JHS Svendgaard Laboratories Share Price

7.90+0.04 (+0.51%)
-29.27% past 1 Year

JHS Svendgaard Laboratories Limited is engaged in manufacturing a range of oral and dental products. The portfolio of the Company is to carry out manufacturing, exporting, importing and trading of

Corporate filings & documents

Announcements

Newspaper Publication regarding dispatch of 22nd AGM Notice
21 hours ago
Newspaper Publication regarding dispatch of 22nd AGM Notice
21 hours ago
Notice of 22nd Annual General Meeting of the Company is scheduled to be held on September 26 2026 at 3:00 PM
1 day ago
Notice of 22nd Annual General Meeting of the Company is scheduled to be held on September 26 2026 at 3:00 PM
1 day ago
Annual Report for the Financial Year 2025-26
1 day ago
Annual Report for the Financial Year 2025-26
1 day ago
JHS Svendgaard Laboratories Limited has informed about the publication of Newspaper Advertisement regarding the details of Annual General Meeting.
5 days ago
JHS Svendgaard Laboratories Limited has informed about the publication of Newspaper Advertisement regarding the details of Annual General Meeting.
5 days ago
Newspaper Publication of Un- Audited Financial Results for the Quarter Ended June 30 2026.
3 weeks ago
Newspaper Publication of Un- Audited Financial Results for the Quarter Ended June 30 2026.
3 weeks ago
Statement of Deviation and Variation for the Quarter Ended 30th June 2026
3 weeks ago
Statement of Deviation and Variation for the Quarter Ended 30th June 2026
3 weeks ago
The Board of Directors approved the Un-Audited Financial Results for the Quarter Ended 30th June 2026
3 weeks ago
The Board of Directors approved the Un-Audited Financial Results for the Quarter Ended 30th June 2026
3 weeks ago
The Board of Directors in its meeting held on 11th August 2026 inter alia Considered and Approved the Un-Audited Financial Results for the Quarter Ended 30th June 2026
3 weeks ago
The Board of Directors in its meeting held on 11th August 2026 inter alia Considered and Approved the Un-Audited Financial Results for the Quarter Ended 30th June 2026
3 weeks ago
JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Un-Audited Financial Results for the Quarter Ended 30 June 2026
1 month ago
JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Un-Audited Financial Results for the Quarter Ended 30 June 2026
1 month ago
Voting Results and Scrutinizer Report of Postal Ballot of the company concluded on 29 July 2026.
1 month ago
Voting Results and Scrutinizer Report of Postal Ballot of the company concluded on 29 July 2026.
1 month ago
Proceedings of Postal Ballot by Remote E-Voting Process by Members of the Company concluded on July 29 2026.
1 month ago
Proceedings of Postal Ballot by Remote E-Voting Process by Members of the Company concluded on July 29 2026.
1 month ago
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
1 month ago
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018
1 month ago
Newspaper Publication of Postal Ballot Notice dated 29 June 2026.
2 months ago
Newspaper Publication of Postal Ballot Notice dated 29 June 2026.
2 months ago
Notice of Postal Ballot
2 months ago
Notice of Postal Ballot
2 months ago
Outcome of Board meeting regarding variation in the utilization of proceeds raised through preferential issue as approved by shareholders through postal ballot on June 23 2025.
2 months ago
Outcome of Board meeting regarding variation in the utilization of proceeds raised through preferential issue as approved by shareholders through postal ballot on June 23 2025.
2 months ago
Intimation of closure of Trading Window for Quarter ended June 30 2026.
2 months ago
Intimation of closure of Trading Window for Quarter ended June 30 2026.
2 months ago
Newspaper Publication of Audited Financial Results for Quarter and Year ended March 31 2026
3 months ago
Statement of Deviation for Quarter ended 31 March 2026.
3 months ago
Statement of Deviation for Quarter ended 31 March 2026.
3 months ago
Audited Financial Result for quarter and year ended 31 March 2026.
3 months ago
Audited Financial Result for quarter and year ended 31 March 2026.
3 months ago
The Board of Directors of the company inter alia considered and approved the Audited Financial Results of the Company for the quarter and financial year ended March 31 2025 today in its Board Meeting dated May 26 2026.
3 months ago
The Board of Directors of the company inter alia considered and approved the Audited Financial Results of the Company for the quarter and financial year ended March 31 2025 today in its Board Meeting dated May 26 2026.
3 months ago
Annual Secretarial Compliance report for the Year Ended 31st March 2026
3 months ago
Annual Secretarial Compliance report for the Year Ended 31st March 2026
3 months ago
JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 inter alia to consider and approve Audited Financial Results for the Quarter and Year Ended 31st March 2026
3 months ago
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>JHS Svendgaard Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74110HP2004PLC027558</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>13.87</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Komal Jha <br/> Designation: Compliance Officer and Company Secretary <br/> EmailId: [email protected]</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Ashish Goel <br/> Designation: Chief Financial Officer <br/> EmailId: [email protected]</div> </div> <div> <br/> Date: 30/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>
4 months ago
Intimation under regulation 7 and 30 of SEBI (LODR) Regulation 2015 the Company has entered into a tripartite Agreement between issuer Old RTA and New RTA on dated 27.04.2026
4 months ago
Intimation under regulation 7 and 30 of SEBI (LODR) Regulation 2015 the Company has entered into a tripartite Agreement between issuer Old RTA and New RTA on dated 27.04.2026
4 months ago
JHS Svendgaard Laboratories Limited informs Compliance Certificate under Regulation 74(5) of SEBI (Depositories Participants) Regulation 2018.
4 months ago
Update on the change of Registrar and Transfer Agent(RTA)
4 months ago
Newspaper Publication in Support of Investor Education Protection Fund Authority second 100 days campaign
4 months ago
Newspaper Publication in Support of Investor Education Protection Fund Authority second 100 days campaign
4 months ago
Copy of Newspaper Publication for opening of Single Window for Re-Lodgment of transfer requests of Physical Shares as per the SEBI Circular dated January 30 2026.
5 months ago

Concalls & investor presentations

May 2024
ConcallPresentation
May 2024
Feb 2024
Nov 2023
ConcallPresentation
Nov 2023
May 2023
ConcallPresentation
May 2023
Nov 2022
ConcallPresentation
Nov 2022
Aug 2022
May 2022
ConcallPresentation
May 2022
Feb 2022
Nov 2021
ConcallPresentation
Nov 2021
Aug 2021

Corporate Actions

Date
Type
Details
2011-12-26
Dividend
0.75
2010-12-22
Dividend
0.5

Company details

Registered office

Trilokpur Road Kheri (Kala- Amb) Tehsil- Nahan Sirmour Dist Himachal Pradesh PIN: 173030 Tel No: 01702-302119 / 121 / 102 / 9218400346 Fax No: 01702-302125 / 238831 Email: [email protected] Internet: www.svendgaard.com

Registrars

Beetal House , 99 Mandangir,3rd Floor, Behind Local Shopping Centre,Near Dada Harsukhdas Mandir,New Delhi Beetal House , 99 Mandangir 3rd Floor, Behind Local Shopping Centre Near Dada Harsukhdas Mandir PIN: Tel No: 011-29961281 -82 Fax No: 011-29961284 Email: NULL

Management

Komal Jha, Company Secretary & Compliance Officer

Rajagopal Chakravarthi Venkateish, Chairman

Nikhil Nanda, Managing Director

Upma Chawdhry, Non Executive Independent Women Director

Kapil Minocha, Non Executive Independent Director

Vinay Mittal, Non Independent & Non Executive Director

Paramvir Singh, Executive Director & Chief Execu??ve Officer

Details

BSE 532771

NSE JHS

ISIN INE544H01014

JHS Svendgaard Laboratories Ltd Share Price Today

The JHS Svendgaard Laboratories Ltd share price today is ₹7.96. During the trading session, the JHS Svendgaard Laboratories Ltd share price opened at ₹7.81 and recorded an intraday high of ₹8.04 and a low of ₹7.81. Last closing price was ₹7.81. Over the past 52 weeks, the JHS Svendgaard Laboratories Ltd share price has ranged between ₹6.26 and ₹13.90. The current JHS Svendgaard Laboratories Ltd stock price reflects real-time market activity based on executed trades on the exchange.